Chill Medicated

Chill Medicated has shown notable performance in the Massachusetts market, particularly in the Beverage category, where it maintained a steady rank of 6th place in November and December 2025 before improving to 5th place in January and February 2026. This upward movement is indicative of growing consumer preference or effective market strategies. In the Topical category, Chill Medicated held a strong position at 3rd place through November to January, before slipping to 4th place in February. This slight decline might signal increasing competition or shifting consumer trends. It's also worth noting that in the Tincture & Sublingual category, the brand consistently held the 6th position from November to January, but did not appear in the top 30 in February, which could be a potential area of concern or an opportunity for strategic reassessment.

In Michigan, Chill Medicated has firmly established itself as the top brand in the Topical category, consistently holding the 1st position from November 2025 to February 2026. However, there was a noticeable decrease in sales from December to February, which might suggest market saturation or seasonal fluctuations. In the Beverage category, the brand experienced fluctuations, starting at 8th place in November, dropping to 9th in December and January, and then climbing back to 6th place in February. Meanwhile, in New Jersey, Chill Medicated made a significant entry into the Beverage category, ranking 3rd in December 2025 and maintaining that position in January 2026. The absence of data for November and February might suggest either a new market entry or a temporary withdrawal from the top ranks, which could be an area for further exploration.